
OptoCeutics (a combination of Optical & Pharmaceutics) was established in 2018 as a university spin-out based on a world patent from collaborative research at Danish Technical University (DTU) and University of California Berkeley (UCB).
We are advancing the field of
Here’s the inside story of our passionate co-founder and CEO, Ngoc Mai Nguyen, and her entrepreneurial journey with OptoCeutics.
Watch this video to find how a group of scholars developed and patented a potential solution to neurodegenerative disease in record time.
OptoCeutics solutions are developed to meet these three goals:
We engage in a dialogue with patients, their families and practitioners early in the development to be aligned with their needs and preferences.
We develop solutions that are comfortable, safe to use, and completely non-invasive.
The solution is to be used in the comfort of your own home. It is convenient and easily implementable in the everyday life.
Sign-up to our newsletter and receive new information about our developments, clinical trials and more.